CanVECTOR Network
@canvector.bsky.social
The Canadian Venous Thromboembolism Research Network (CanVECTOR), pan-Canadian, patient-oriented, Community Development Program centred on venous thromboembolism (VTE) related research, training, and knowledge translation.
Attention Trainees: We're accepting applications for our 2025 Studentship Awards (Deadline: May 16th) and Travel Awards (Deadline: May 9th) to #ISTH2025 🎓✈️
Learn more: bit.ly/436JvId
#CanVECTOR #VTEresearch #Thrombosis #MedTwitter
Learn more: bit.ly/436JvId
#CanVECTOR #VTEresearch #Thrombosis #MedTwitter
May 5, 2025 at 6:03 PM
Attention Trainees: We're accepting applications for our 2025 Studentship Awards (Deadline: May 16th) and Travel Awards (Deadline: May 9th) to #ISTH2025 🎓✈️
Learn more: bit.ly/436JvId
#CanVECTOR #VTEresearch #Thrombosis #MedTwitter
Learn more: bit.ly/436JvId
#CanVECTOR #VTEresearch #Thrombosis #MedTwitter
Reposted by CanVECTOR Network
We @ISTH.org greatly value our 🇨🇦 members & colleagues & their important contributions to global #thrombosis & #hemostasis.
🚨 Don't miss this important @canvector.bsky.social CALL FOR APPLICATIONS for Studentship Awards & Travel Awards to #ISTH2025.
📆 Deadline: May 16, 2025
bit.ly/3EAu7va
🚨 Don't miss this important @canvector.bsky.social CALL FOR APPLICATIONS for Studentship Awards & Travel Awards to #ISTH2025.
📆 Deadline: May 16, 2025
bit.ly/3EAu7va
April 24, 2025 at 2:31 PM
We @ISTH.org greatly value our 🇨🇦 members & colleagues & their important contributions to global #thrombosis & #hemostasis.
🚨 Don't miss this important @canvector.bsky.social CALL FOR APPLICATIONS for Studentship Awards & Travel Awards to #ISTH2025.
📆 Deadline: May 16, 2025
bit.ly/3EAu7va
🚨 Don't miss this important @canvector.bsky.social CALL FOR APPLICATIONS for Studentship Awards & Travel Awards to #ISTH2025.
📆 Deadline: May 16, 2025
bit.ly/3EAu7va
Reposted by CanVECTOR Network
Calling early-career researchers who submitted an abstract to #ISTH2025! We are accepting apps for the Fundamental Research Career Development Award until March 3! The award is designed to advance the understanding, prevention & treatment of thrombosis and hemostasis: www.isth.org/page/frcda?_...
January 29, 2025 at 6:51 PM
Calling early-career researchers who submitted an abstract to #ISTH2025! We are accepting apps for the Fundamental Research Career Development Award until March 3! The award is designed to advance the understanding, prevention & treatment of thrombosis and hemostasis: www.isth.org/page/frcda?_...
"Doctor, I am 83 years old and have been taking warfarin for atrial fibrillation. Would switching to a newer blood thinner reduce my risk of bleeding?"
New Clot+ patient Evidence Summary now available summarizing the research to this important question.
bit.ly/3PVzuar
New Clot+ patient Evidence Summary now available summarizing the research to this important question.
bit.ly/3PVzuar
January 29, 2025 at 7:38 PM
"Doctor, I am 83 years old and have been taking warfarin for atrial fibrillation. Would switching to a newer blood thinner reduce my risk of bleeding?"
New Clot+ patient Evidence Summary now available summarizing the research to this important question.
bit.ly/3PVzuar
New Clot+ patient Evidence Summary now available summarizing the research to this important question.
bit.ly/3PVzuar
WEBINAR: The NLRP3 Inflammasome and Interleukin-1 in Thromboinflammation and #VTE
Join us for the next edition of our National Thrombosis Seminar series on February 4th at 11 am ET !
Featuring: Nicola Potere, MD
Register: buff.ly/4g04UHl
#Thrombosis #Research
Join us for the next edition of our National Thrombosis Seminar series on February 4th at 11 am ET !
Featuring: Nicola Potere, MD
Register: buff.ly/4g04UHl
#Thrombosis #Research
Welcome! You are invited to join a webinar: CanVECTOR National Thrombosis Seminars - February 4, 2025. After registering, you will receive a confirmation email about joining the webinar.
Join us for the next edition of the 2024-2025 CanVECTOR National Thrombosis Seminar Series on Tuesday, February 4, 2025 at 11:00 a.m. ET.
Topic: The NLRP3 Inflammasome and Interleukin-1 in Thromboinf...
buff.ly
January 16, 2025 at 5:29 PM
WEBINAR: The NLRP3 Inflammasome and Interleukin-1 in Thromboinflammation and #VTE
Join us for the next edition of our National Thrombosis Seminar series on February 4th at 11 am ET !
Featuring: Nicola Potere, MD
Register: buff.ly/4g04UHl
#Thrombosis #Research
Join us for the next edition of our National Thrombosis Seminar series on February 4th at 11 am ET !
Featuring: Nicola Potere, MD
Register: buff.ly/4g04UHl
#Thrombosis #Research
WEBINAR - Today at 11am ET !
Join us for a special National Thrombosis Seminar on "Incorporating Equity, Diversity, & Inclusion in #VTE #Research Design and Implementation"
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
Register: buff.ly/40kCrGz
#Thrombosis
Join us for a special National Thrombosis Seminar on "Incorporating Equity, Diversity, & Inclusion in #VTE #Research Design and Implementation"
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
Register: buff.ly/40kCrGz
#Thrombosis
January 8, 2025 at 3:20 PM
WEBINAR - Today at 11am ET !
Join us for a special National Thrombosis Seminar on "Incorporating Equity, Diversity, & Inclusion in #VTE #Research Design and Implementation"
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
Register: buff.ly/40kCrGz
#Thrombosis
Join us for a special National Thrombosis Seminar on "Incorporating Equity, Diversity, & Inclusion in #VTE #Research Design and Implementation"
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
Register: buff.ly/40kCrGz
#Thrombosis
WEBINAR: Join us for the next edition of our National Thrombosis Seminar series on January 8th at 11 am ET on "Incorporating EDI in VTE Research Design and Implementation" !
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
buff.ly/40kCrGz
#VTE #Thrombosis #Research
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
buff.ly/40kCrGz
#VTE #Thrombosis #Research
Welcome! You are invited to join a webinar: CanVECTOR National Thrombosis Seminars - January 8, 2025. After registering, you will receive a confirmation email about joining the webinar.
Join us for the next edition of the 2024-2025 CanVECTOR National Thrombosis Seminar Series on Wednesday, January 8, 2025 at 11:00 a.m. ET.
Topic: Shining a Spotlight on (In)visible Minority Groups: I...
buff.ly
January 1, 2025 at 8:13 PM
WEBINAR: Join us for the next edition of our National Thrombosis Seminar series on January 8th at 11 am ET on "Incorporating EDI in VTE Research Design and Implementation" !
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
buff.ly/40kCrGz
#VTE #Thrombosis #Research
Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc
buff.ly/40kCrGz
#VTE #Thrombosis #Research
Reposted by CanVECTOR Network
💡Outstanding mentorship can have a critically positive impact on the lives and careers of #ISTHearlycareer professionals.
👋Help us recognize outstanding mentors through this important @isth-official.bsky.social
Award. 🏆
🗓️Application Deadline is January 6!
➡️https://buff.ly/49Im4aW
#HemeSky
👋Help us recognize outstanding mentors through this important @isth-official.bsky.social
Award. 🏆
🗓️Application Deadline is January 6!
➡️https://buff.ly/49Im4aW
#HemeSky
December 18, 2024 at 3:30 PM
💡Outstanding mentorship can have a critically positive impact on the lives and careers of #ISTHearlycareer professionals.
👋Help us recognize outstanding mentors through this important @isth-official.bsky.social
Award. 🏆
🗓️Application Deadline is January 6!
➡️https://buff.ly/49Im4aW
#HemeSky
👋Help us recognize outstanding mentors through this important @isth-official.bsky.social
Award. 🏆
🗓️Application Deadline is January 6!
➡️https://buff.ly/49Im4aW
#HemeSky
🎉 Exciting News! 🎉
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
December 18, 2024 at 5:24 PM
🎉 Exciting News! 🎉
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
We are thrilled to announce that Dr. Deborah Siegal has been appointed as the next Co-Director of CanVECTOR (joining Co-Director Dr. Grégoire Le Gal), starting April 1, 2025!
Learn more: 🔗
buff.ly/4gHeS1a
#Research #Thrombosis #VTE
Join us today at 11:00 am ET | 4pm UTC | 5pm CET for our webinar titled: The Winding Road to Personalized
#Antithrombotic Therapy: A Translational Perspective
Featuring: Hugo ten Cate, MD, PhD, Maastricht University
Register: buff.ly/3CXrHWd
#Thrombosis #Research #VTE
#Antithrombotic Therapy: A Translational Perspective
Featuring: Hugo ten Cate, MD, PhD, Maastricht University
Register: buff.ly/3CXrHWd
#Thrombosis #Research #VTE
Welcome! You are invited to join a webinar: CanVECTOR National Thrombosis Seminars - December 12, 2024. After registering, you will receive a confirmation email about joining the webinar.
Join us for the launch of the of the 2024-2025 CanVECTOR National Thrombosis Seminar Series on Thursday, December 12, 2024 at 11:00 a.m. ET.
Topic: The Winding Road to Personalized Antithrombotic The...
buff.ly
December 12, 2024 at 3:17 PM
Join us today at 11:00 am ET | 4pm UTC | 5pm CET for our webinar titled: The Winding Road to Personalized
#Antithrombotic Therapy: A Translational Perspective
Featuring: Hugo ten Cate, MD, PhD, Maastricht University
Register: buff.ly/3CXrHWd
#Thrombosis #Research #VTE
#Antithrombotic Therapy: A Translational Perspective
Featuring: Hugo ten Cate, MD, PhD, Maastricht University
Register: buff.ly/3CXrHWd
#Thrombosis #Research #VTE
Reposted by CanVECTOR Network
Big night for the @uOttawa at #ASH24!
Drs. Shaw and Siegal received the Early-Career and Best Paper awards from the Canadian Society of Hematology 🏆
Dr. Shaw’s work on TGA and Dr. Siegal’s on the Stratus trial have been transformative ! Congrats!
Drs. Shaw and Siegal received the Early-Career and Best Paper awards from the Canadian Society of Hematology 🏆
Dr. Shaw’s work on TGA and Dr. Siegal’s on the Stratus trial have been transformative ! Congrats!
December 9, 2024 at 4:25 PM
Big night for the @uOttawa at #ASH24!
Drs. Shaw and Siegal received the Early-Career and Best Paper awards from the Canadian Society of Hematology 🏆
Dr. Shaw’s work on TGA and Dr. Siegal’s on the Stratus trial have been transformative ! Congrats!
Drs. Shaw and Siegal received the Early-Career and Best Paper awards from the Canadian Society of Hematology 🏆
Dr. Shaw’s work on TGA and Dr. Siegal’s on the Stratus trial have been transformative ! Congrats!
Reposted by CanVECTOR Network
Measurement of DOACs is challenging. Although the level can influence outcomes, there is no data on dose adjustments.
Dr. Siegal also reminded us that standard coagulation tests can provide qualitative assessment but may miss “on-treatment” levels.
#ASH24
Dr. Siegal also reminded us that standard coagulation tests can provide qualitative assessment but may miss “on-treatment” levels.
#ASH24
December 9, 2024 at 6:46 PM
Measurement of DOACs is challenging. Although the level can influence outcomes, there is no data on dose adjustments.
Dr. Siegal also reminded us that standard coagulation tests can provide qualitative assessment but may miss “on-treatment” levels.
#ASH24
Dr. Siegal also reminded us that standard coagulation tests can provide qualitative assessment but may miss “on-treatment” levels.
#ASH24
Reposted by CanVECTOR Network
Excellent 🇨🇦representation (including some honorary Canadians 🙃) at @ash-hematology.bsky.social 🏃♀️ this morning.
Biggest Type Eh! Running group ever!
Biggest Type Eh! Running group ever!
December 8, 2024 at 5:05 PM
Excellent 🇨🇦representation (including some honorary Canadians 🙃) at @ash-hematology.bsky.social 🏃♀️ this morning.
Biggest Type Eh! Running group ever!
Biggest Type Eh! Running group ever!